Biotech Startup Autolus Closes $80 Million for Novel Cancer Program
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-investor.jpg" NAME"Biotech Startup Autolus Closes $80 Million for Novel Cancer Program" ALT"Biotech Startup Autolus Closes $80 Million for Novel Cancer Program"September 26, 2017By Alex Keown, BioSpace.com Breaking News Staff...…
Judge Sets Oct. 17 for Next Industry Challenge to Nevada Price Law
A federal judge in Nevada set a hearing for Oct. 17 on a move by BIO and PhRMA to block the state’s new law on price transparency for diabetes drugs,…
Native American Tribe Moves to Dismiss Challenge to Holding of Allergan Patents
The Saint Regis Mohawk tribe asked a federal agency to dismiss several challenges of the patents it now holds for Allergan, arguing the tribe is a sovereign nation and immune…
FDA Calls for Further Studies for Intellipharmaceutics’ Rexista
The FDA sent Intellipharmaceutics a complete response letter for Rexista — an extended-release oxycodone tablet rejected in July by an FDA advisory committee — calling for additional studies of the…
FDA Crackdown on Illegal Online Pharmacies Part of Broad International Effort
The FDA recently took action against more than 500 websites for illegally selling unapproved prescription medicines through the mail — including opioids, antibiotics and injectable epinephrine — as part of…
FDA, OHRP Finalize Guidance on IRB Meeting Minutes
The FDA and the HHS Office of Human Research Protections finalized their joint guidance detailing requirements for keeping minutes of institutional review board meetings, as part of a push to…
Interim CEO Named Permanent Leader at Tango Therapeutics
September 25, 2017By Mark Terry, BioSpace.com Breaking News... Source: BioSpace
22nd Century Group, Inc. Now Free Of Restrictive License Agreement With
Life Sciences Jobs ... Source: BioSpace
- Go to the previous page
- 1
- …
- 308
- 309
- 310
- 311
- 312
- 313
- 314
- …
- 610
- Go to the next page